PP
FMI

Peconic Partners’s Foundation Medicine, Inc. FMI Stock Holding History

Peconic Partners’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-90,147
Closed -$1.6M – 57
2016
Q4 		$1.6M Hold
90,147
– – 0.21% 32
2016
Q3 		$2.1M Buy
+90,147
New +$2.05M 0.27% 28

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Peconic Partners's FMI Position: Q1 2017 in Review

Peconic Partners sold out of Foundation Medicine, Inc. (FMI) in Q1 2017, closing a stake of 90,147 shares — an estimated $1.6M sold.

Peconic Partners first reported a position in FMI in Q3 2016 and held it in 2 quarters. The position peaked at $2.1M in Q3 2016. 93 funds tracked by Wall St. Rank hold FMI as of Q1 2017.

  • Peconic Partners reported no remaining Foundation Medicine, Inc. position as of Q1 2017 after selling out during the quarter.
  • Peconic Partners sold 90,147 Foundation Medicine, Inc. shares in Q1 2017, an estimated $1.6M.
  • Peconic Partners first reported a position in Foundation Medicine, Inc. in Q3 2016 and held it in 2 quarters.
  • Peconic Partners's Foundation Medicine, Inc. position peaked at $2.1M in Q3 2016.
  • 93 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2017.

Based on Peconic Partners's 13F filing for Q1 2017, filed 15 May 2017.